191 related articles for article (PubMed ID: 10713653)
1. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
Chen YC; Cheng TT; Lai HM; Wu CH
Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
3. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
Jedlickova H; Bohmová J; Sirotkova A
Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
[No Abstract] [Full Text] [Related]
4. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
5. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
[TBL] [Abstract][Full Text] [Related]
6. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
7. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
[TBL] [Abstract][Full Text] [Related]
8. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
[No Abstract] [Full Text] [Related]
9. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.
Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological therapy of lupus nephritis.
Fine DM
JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lupus nephritis--a work in progress.
Falk RJ
N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
[No Abstract] [Full Text] [Related]
14. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
15. Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis.
Ueda Y; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):99-104. PubMed ID: 21628852
[TBL] [Abstract][Full Text] [Related]
16. A burden to bear in systemic lupus erythematosus (SLE).
Pussell BA
Aust N Z J Med; 1998 Aug; 28(4):483-4. PubMed ID: 9777128
[No Abstract] [Full Text] [Related]
17. Clinical trials in lupus nephritis.
Ginzler EM
Curr Rheumatol Rep; 2001 Jun; 3(3):199-204. PubMed ID: 11352788
[TBL] [Abstract][Full Text] [Related]
18. Treatment of proliferative lupus nephritis: a changing landscape.
Adu D
Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
20. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
